Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Recruiting now

Conditions studied: Polycystic Ovarian Syndrome (PCOS)

In brief

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Key facts

Study ID

NCT06642831

Run by

University Hospital Erlangen

People needed

380

Starts

2023-01-31

Expected to finish

2027-03-01

Last updated by the study team

2024-10-15

Who can join

Age: 15 and older, up to 25. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female subjects age 15-25 years
• Signed written informed consent

You may not qualify if…

• Less than 1 years from onset of menarche
• Use of hormonal contraceptives
• Documented ongoing pregnancy
• Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses > 2 cm as detected by transvaginal ultrasound
• Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)

Where it is running

• Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany — Erlangen, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.